AI startup Lunit has received the approval of Singapore's Health Sciences Authority to commercialise its AI diagnostic tools for analysing chest x-ray and breast mammography.
WHAT THEY DO
Both AI products are under the Lunit INSIGHT product line. According to a press statement, the Lunit INSIGHT CXR and INSIGHT MMG provide lesion detection with around 96-99% accuracy and visualise the location of...
